Dr. Peter Hersh, MD
Claim this profileThe cornea & Laser Eye Institute-NJ
Studies Keratoconus
Studies Corneal Ectasia
8 reported clinical trials
8 drugs studied
Affiliated Hospitals
Clinical Trials Peter Hersh, MD is currently running
Corneal Collagen Crosslinking
for Keratoconus
This study is being conducted to evaluate the safety and efficacy of isotonic riboflavin for corneal collagen crosslinking for keratoconus and corneal ectasia. will determine the safety and efficacy of corneal collagen crosslinking (CXL) performed with two different riboflavin formulations for reducing corneal curvature.
Recruiting3 awards Phase 3
Corneal Collagen Crosslinking
for Keratoconus
Corneal collagen crosslinking (CXL) has been demonstrated as an effective method of reducing progression of both keratoconus and corneal ectasia after surgery, as well as possibly decreasing the steepness of the cornea in these pathologies. Transepithelial crosslinking in which the epithelium is not removed has been proposed to offer a number of advantages over traditional crosslinking including an increased safety profile by reducing the risk for infection and scarring, faster visual recovery and improved patient comfort in the early postoperative healing period.
Recruiting3 awards Phase 3
More about Peter Hersh, MD
Clinical Trial Related4 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Peter Hersh, MD has experience with
- Riboflavin
- PXL Platinum 330 System With Riboflavin Solution
- Corneal Collagen Crosslinking (CXL)
- Intacs
- Corneal Collagen Crosslinking
- Hypotonic Riboflavin
Breakdown of trials Peter Hersh, MD has run
Keratoconus
Corneal Ectasia
Corneal Disorder
Corneal Ulcer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Peter Hersh, MD specialize in?
Peter Hersh, MD focuses on Keratoconus and Corneal Ectasia. In particular, much of their work with Keratoconus has involved treating patients, or patients who are undergoing treatment.
Is Peter Hersh, MD currently recruiting for clinical trials?
Yes, Peter Hersh, MD is currently recruiting for 2 clinical trials in Teaneck New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Peter Hersh, MD has studied deeply?
Yes, Peter Hersh, MD has studied treatments such as Riboflavin, PXL Platinum 330 System with Riboflavin Solution, Corneal Collagen Crosslinking (CXL).
What is the best way to schedule an appointment with Peter Hersh, MD?
Apply for one of the trials that Peter Hersh, MD is conducting.
What is the office address of Peter Hersh, MD?
The office of Peter Hersh, MD is located at: The cornea & Laser Eye Institute-NJ, Teaneck, New Jersey 07666 United States. This is the address for their practice at the The cornea & Laser Eye Institute-NJ.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.